Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities
J. Clin. Invest. Tilo Grosser, et al. 116:4
doi:10.1172/JCI27291 [Go to this article.]

Problems with a PDF?